Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.

Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, Marron JS, Routh ED, Caskey LS, Samuel JC, Der CJ, Thorne LB, Calvo BF, Kim HJ, Talamonti MS, Iacobuzio-Donahue CA, Hollingsworth MA, Perou CM, Yeh JJ.

PLoS Med. 2010 Jul 13;7(7):e1000307. doi: 10.1371/journal.pmed.1000307.

2.

A phase I study of bortezomib in combination with standard 5-fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic rectal cancer.

O'Neil BH, Raftery L, Calvo BF, Chakravarthy AB, Ivanova A, Myers MO, Kim HJ, Chan E, Wise PE, Caskey LS, Bernard SA, Sanoff HK, Goldberg RM, Tepper JE.

Clin Colorectal Cancer. 2010 Apr;9(2):119-25. doi: 10.3816/CCC.2010.n.017.

3.

The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation.

Feng SM, Muraoka-Cook RS, Hunter D, Sandahl MA, Caskey LS, Miyazawa K, Atfi A, Earp HS 3rd.

Mol Cell Biol. 2009 Feb;29(3):892-906. doi: 10.1128/MCB.00595-08. Epub 2008 Dec 1.

4.

The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.

Feng SM, Sartor CI, Hunter D, Zhou H, Yang X, Caskey LS, Dy R, Muraoka-Cook RS, Earp HS 3rd.

Mol Endocrinol. 2007 Aug;21(8):1861-76. Epub 2007 May 15.

5.

Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.

Muraoka-Cook RS, Caskey LS, Sandahl MA, Hunter DM, Husted C, Strunk KE, Sartor CI, Rearick WA Jr, McCall W, Sgagias MK, Cowan KH, Earp HS 3rd.

Mol Cell Biol. 2006 Sep;26(17):6412-24.

6.

Human epidermal receptor-2 expression in prostate cancer.

Calvo BF, Levine AM, Marcos M, Collins QF, Iacocca MV, Caskey LS, Gregory CW, Lin Y, Whang YE, Earp HS, Mohler JL.

Clin Cancer Res. 2003 Mar;9(3):1087-97.

7.

Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.

Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK.

Clin Cancer Res. 2002 Jan;8(1):117-23.

8.

Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.

Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W.

Histol Histopathol. 2000 Jul;15(3):971-81. doi: 10.14670/HH-15.971. Review.

PMID:
10963139
9.

Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.

Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK, Zhang W.

Cancer Res. 1999 Sep 1;59(17):4228-32.

10.

Cleavage of the C-terminus of NEDD8 by UCH-L3.

Wada H, Kito K, Caskey LS, Yeh ET, Kamitani T.

Biochem Biophys Res Commun. 1998 Oct 29;251(3):688-92.

PMID:
9790970
11.

Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.

Gong L, Kamitani T, Fujise K, Caskey LS, Yeh ET.

J Biol Chem. 1997 Nov 7;272(45):28198-201.

12.

Binding-protein-dependent arginine transport in Pasteurella haemolytica.

Caskey LS, Lamphear JG, Highlander SK.

Microbiology. 1996 Jul;142 ( Pt 7):1739-47.

PMID:
8757738
13.

The influenza B virus mouse model of Reye's syndrome: pathogenesis of the hypoglycaemia.

Davis LE, Woodfin BM, Tran TQ, Caskey LS, Wallace JM, Scremin OU, Blisard KS.

Int J Exp Pathol. 1993 Jun;74(3):251-8.

14.

Influenza A virus in the mouse: hepatic and cerebral lesions in a Reye's syndrome-like illness.

Sanchez-Lanier M, Davis LE, Blisard KS, Woodfin BM, Wallace JM, Caskey LS.

Int J Exp Pathol. 1991 Oct;72(5):489-500.

Supplemental Content

Loading ...
Support Center